Juicero
Juicero
USA, Founded 2013
Society
2/10
Customer
2/10
Self
2/10
25 below the survival line
Society
2/10
Customer
2/10
Self
2/10
25 below the survival line
Raised $120M to build a $400 juicer. It was faster to squeeze the packet by hand.
12 criteria
16/60
3 axes
6/30
NCG
22/100
Context
Doug Evans founded Juicero aiming to be 'the Keurig of juice.' The model was a $400 Wi-Fi-enabled juicer plus proprietary packets at $5–8 each. A Bloomberg reporter showed that hand-squeezing the packet produced the same juice, and the reason for the product's existence evaporated. The $120M raise was wasted.
Teles' Insight
Juicero died from 'putting $120M into a market where the problem doesn't exist.' A $400 Wi-Fi-enabled juicer plus $5–8 proprietary packets. A single sentence from a Bloomberg reporter — 'you get the same juice if you squeeze the packet by hand' — erased all of the value. Google Ventures and Kleiner Perkins were invested, and yet no one had squeezed the packet by hand. A symbol of the Silicon Valley era that confused 'technology' with 'value.' A simple customer-side product test could have prevented it.
Why it failed
They didn't solve a customer's pain; they solved the founder's technology aesthetic. The moment 'you can squeeze the packet by hand' was exposed, the $400 price and $120M of funding evaporated together with the product's reason to exist. The inevitable consequence of an insight score of 1.
12 Criteria (16/60)
WeaknessesA Market, B Problem, C Solution, D Team, E Traction, F Moat, G Revenue, H Financial, I Efficiency, J Exit, K Timing, L Insight
Healthy juice market exists — a $400 machine isn't needed.
'Making juice is a hassle' is a weak problem.
A $400 Wi-Fi-enabled juicer. Peak over-engineering.
Juice experts, but tech amateurs.
Near zero. $400 price was the wall.
None. Evaporated the instant 'you can squeeze the packet by hand' was proven.
Hardware + subscription packets. Hardware didn't sell.
Raised $120M and burned it. Revenue near zero.
One of the most capital-inefficient startups ever.
Shut down in 2017.
Health trends existed, but $400 was a non-starter.
None. Put $120M into a market where the problem didn't exist.
